MRSH CEO Dean Michael Klisura Sells $839K of Stock

On October 23, 2026, Dean Michael Klisura, President & CEO of Marsh RE, sold 4,194 shares of Marsh & McLennan Companies, Inc. (MRSH) for a total of $838,800. This transaction was reported in a Form 4 filing with the SEC. Following this sale, Klisura's total ownership in the company decreased by about 16.69%, leaving him with approximately 20,935 shares.

Klisura's sale comes as Marsh & McLennan shares closed at $197.48 on October 23, 2026. Since then, the stock has traded recently around $193.70, which is about 1.9% below that closing price. The stock is currently above its 50-day and 200-day moving averages, suggesting a positive trend in the longer term. However, it remains about 3.3% below its 52-week high of $200.33.

MRSH Marsh & McLennan Companies, Inc.

$197.48 ▲ +10.60% year to date

1M 3M YTD

Daily close · Oct 23, 2026

Other Institutional Activity in Marsh & McLennan

Several other institutional investors have adjusted their positions in Marsh & McLennan recently. Quilter reduced its stake by 17,215 shares, ending with 236,492 shares worth about $40.4 million. In contrast, Ninety One UK increased its holdings by 1,661,178 shares, bringing its total to 5,632,700 shares valued at approximately $961.7 million. Abc Arbitrage and AMF Tjanstepension both sold out entirely, with Abc Arbitrage offloading 31,663 shares and AMF Tjanstepension clearing its position of 257,521 shares. Meanwhile, Capital International Investors slightly increased its stake, adding 15,714 shares for a total of 15,729,457 shares worth about $3.06 billion.

Marsh & McLennan Companies, Inc. Stock Down 2.8%

Marsh & McLennan shares are currently trading around $193.70, which is below the recent close of $197.48. This price is about 1.9% lower than the closing price on the day of Klisura's sale. The stock is performing well above its 52-week low of $156.60, indicating a strong position in the market.

Recent Earnings

Marsh & McLennan's trailing twelve-month revenue stands at about $28.5 billion, with an earnings per share (EPS) of $8.36. The company has demonstrated a revenue growth of 8.1% year-over-year, and its next earnings report is expected on January 28, 2027.

Analysts Set New Price Targets

Analysts have maintained their ratings on Marsh & McLennan. On October 16, Citigroup kept a Neutral rating with a price target of $203.00, while Wells Fargo maintained an Equal-Weight rating with a target of $197.00. Further, Mizuho and Keefe, Bruyette & Woods both held Neutral ratings with targets of $200.00 and $201.00, respectively. JP Morgan has an Overweight rating with a target of $218.00. The consensus price target for the stock is approximately $205.38.

About Marsh & McLennan Companies, Inc.

Marsh & McLennan Companies, Inc. is a professional services firm that offers advisory services and insurance solutions. It operates in the areas of risk management, strategy, and people, serving clients globally. The company is headquartered in New York and has about 95,000 employees.

Bottom Line

Investors should keep an eye on Marsh & McLennan's upcoming earnings report on January 28, 2027, as well as any further insider transactions. Klisura's recent sale adds to a trend of some institutional investors adjusting their stakes in the company.